<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig2">
 <label>Fig. 2</label>
 <caption>
  <p>Diagram of a quality risk management model. The emphasis is outlined on the strength that the risk management process must have throughout the graft production cycle, where consideration of all the elements will be incorporated at a level of detail that is proportional to the specific risk</p>
  <p>Reproduced with permission (Yusof 
   <xref ref-type="bibr" rid="CR87">2001</xref>). Copyright 2015, © European Medicines Agency
  </p>
 </caption>
 <graphic xlink:href="10561_2020_9891_Fig2_HTML" id="MO2" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
